Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Kore Group Kore Stock Near Support Price At 9.08 Up 0.44 20260402 Is Regency Regco Stock Breaking Support Price At 22.10 Up 0.23 20260406 Is Universal Uhs Stock Risky Now Price At 178.98 Down 1.00 20260413 Is Burford Bur Stock Near Resistance Price At 4.25 Up 2.54 20260406 Market Moves Tech leads broad gains as consumer sector lags VLYPN Valley National Bancorp 8250 FixedRate Reset NonCumulative Perpetual Preferred Stock Series C outpaces Q4 2025 EPS estimates posts 011 percent gain Redwood RWTO Stock News Market Update Mini Rally 20260418 China SXT SXTC Stock Days to Cover Smart Money Exits 20260415 Jury Set to Deliberate in Musk v Altman Trial After Closing Arguments Conclude Tronox TROX Reports Mixed Q1 2026 Revenue Beats but EPS Misses Germanys Tiger Queen Facility Incident Raises Safety and Insurance Concerns Dave Ramseys Blunt Advice to Uber Driver Who Spent 144K on Cars Youve Been Working for Free Voluntary Repo Weighed US Productivity Growth Slows in Q4 as Labor Costs Accelerate Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Indicates AI Washing UK Companies Stretch Definitions to Rebrand as TechFocused Kevin Warsh to Be Sworn in as Federal Reserve Chair on Friday Valuation Alarms Sounding on Wall Street HighYield Legal Monopoly Under 30 Draws Attention Morgan Stanley Adjusts Edison International Price Target Following April Utility Sector Assessment XCF Global Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Share Rally NDAQ Q1 2026 Earnings EPS Beats Estimates by 111 Revenue Not Disclosed Shares Edge Higher Financial Abuse in Relationships The Case of Ruth Dodsworth and the Hidden Economic Toll EEOC Considers Ending Employer Demographic Data Reporting Requirements Lam Research LRCX Overweight Rating Highlights Potential in 149B Wafer Fabrication Equipment Market FBLG Q1 2026 Earnings Modest EPS Miss Highlights PreRevenue Biotech Path